Lactobacillus rhamnosus GG bacteremia as ... a child with short gut syndrome
Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome.
31
Probiotic agents are increasingly used for the treatment and prevention of a variety of infectious and inflammatory conditions. They are generally safe, but complications of probiotic use can occur. In this report, we describe bacteremia after ingestion of a Lactobacillus rhamnosus GG probiotic tablet in a child with short gut syndrome. We used sequencing of the ribosomal operon region and strain typing with pulsed field electrophoresis of the isolates to show identity between the tablet and bloodstream isolates.
De Groote MA, Frank DN, Dowell E, Glode MP, Pace NR
The Pediatric infectious disease journal
2005-03-01 00:00
24
3
278-80
Anti-Bacterial Agents,Bacteremia,Base Sequence,Catheterization,Combined Modality Therapy,DNA, Bacterial,Drug Therapy, Combination,Follow-Up Studies,Gastrostomy,Gram-Positive Bacterial Infections,Humans,Infant,Lactobacillus,Male,Molecular Sequence Data,Polymerase Chain Reaction,Probiotics,Risk Assessment,Severity of Illness Index,Short Bowel Syndrome,Treatment Outcome,Anti-Bacterial Agents,DNA, Bacterial
University of Colorado Health Sciences Center, Denver, CO, USA
Pediatr. Infect. Dis. J.
0891-3668
00006454-200503000-00022
941
True
15750472